News Features Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond Shelley Wood December 30, 2016
News Features Repaso del Año: Los Médicos Eligen las Noticias Más Importantes de 2016 en Cardiología Intervencionista y Más Shelley Wood December 30, 2016
News Daily News PCSK9 Variants Linked With Lower LDL Cholesterol, Increased Diabetes Risk Michael O'Riordan December 01, 2016
News Daily News Las Variantes del Gen PCSK9 se asocian a Niveles Más Bajos de Colesterol LBD y a un Mayor Riesgo de Diabetes Michael O'Riordan December 01, 2016
News Features Run, Walk, Bike: Doctors Open Up About Their Own Heart-Healthy Exercise Habits Michael O'Riordan November 11, 2016
News Daily News La Endocarditis Infecciosa Post-TAVR se asocia a Diabetes, Regurgitación Aórtica Residual en un Extenso Registro Yael L. Maxwell September 14, 2016
News Daily News Infective Endocarditis After TAVR Linked to Diabetes, Residual Aortic Regurgitation in Large Registry Yael L. Maxwell September 14, 2016
News Daily News Nearly 40% of Diabetic Patients Not Treated With Statins: PINNACLE Registry Michael O'Riordan September 13, 2016
News Daily News Weight Loss May Affect Diabetes Risk, but Not Future CVD Outlook L.A. McKeown August 04, 2016
News Daily News Los Niveles Altos de Lípidos Dictados Genéticamente Parecen Proteger Frente a la Diabetes Tipo 2 Todd Neale August 04, 2016
News Daily News Genetically Dictated Higher Lipid Levels Seem to Protect Against Type 2 Diabetes Todd Neale August 04, 2016
News Daily News The Billions Spent on Healthcare for Sedentary Citizens Warrants Global Response L.A. McKeown July 28, 2016
News Daily News Pokémon Go Forth: Cardiologists, AHA Support Use of Augmented Reality Games That Encourage Movement Yael L. Maxwell July 22, 2016
News Daily News Sitting Pretty: Only Prolonged Sedentary Time Linked With Incident CVD Risk Michael O'Riordan July 15, 2016
News Daily News AstraZeneca Strives to Block Generic Crestor as Observers Call Foul Michael O'Riordan July 13, 2016
News Daily News Time for Niacin to Be ‘Relegated to Medical History’ as HPS2-THRIVE Analysis Confirms Drug’s Failings Michael O'Riordan July 12, 2016